Voices of Biotech
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
- Sponsored Content
- Product Characterization
Advanced Analytical Strategies: From Protein Structure Characterization to Potency Assessment for Challenging Biologic Modalities
BPI Contributor
June 27, 2024
1 Hr View
Date: Jun 27, 2024
Duration: 1 Hr
Sponsored by WuXi Biologics
This webcast features: Tongdan Wang, PhD, Senior Director, Analytical Sciences, WuXi Biologics & Xinyuan Lu, PhD, Senior Director, Analytical Sciences, WuXi Biologics.
In the rapidly evolving landscape of biologics, especially for new modalities like antibody drug conjugates (ADCs) and bispecific/multi-specific antibodies, detailed product characterization evaluation and appropriate potency assessment are crucial for ensuring product quality control and fulfilling regulatory requirements.
This webinar will dive deeper into the following topics:
Deciphering Protein Structure: Advancing Biologics Development Through Product Characterization
Analyze the biologics primary structure, such as CIEF-MS and sequence variant analysis toolboxes, with novel technologies.
Discover tailored approaches for in-depth characterization of ADC, BsAb, and more.
Examine phase-appropriate product characterization strategies during bioprocess development.
Revealing Biologics Efficacy: Advanced Strategies for Potency Assay Development for Multi-Specific Drugs
Learn about risk assessment and mitigation strategies for potency assay development across all drug development stages.
Delve into case studies highlighting potency method development for challenging new modalities including ADC, probodies, BsAb, and MsAbs.
Thank you for your interest in this webcast. You may submit your request to view the webcast, and you will receive a confirmation email with log-in details.
About the Author(s)
You May Also Like
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More
